ConductScience.org, home

Paper2519903

RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release.

Floch A and 5 others. J Lipid Mediat, 1989. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release. Papers, record 2519903. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2519903

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
RP 55778, a PAF receptor antagonist, prevents and reverses LPS-induced hemoconcentration and TNF release.
PubMed
Journal
J Lipid Mediat
PubMed
Year
1989
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
1.3
iCite
Revised in PubMed
2018-11-30
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Floch AA
2Bousseau AA
3Hetier EE
4Floc'h FF
5Bost PEP E
6Cavero II

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Blood VolumeMajor topic
Platelet Activating FactorMajor topic
PyridinesMajor topic
ThiazolesMajor topic
Tumor Necrosis Factor-alphaMajor topic
Animals
Dexamethasone
In Vitro Techniques
Lipopolysaccharides
Macrophages
Male
Mice
RNA, Messenger
Rats

Source PubMed

Download CSV of topics

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
9119469A protective role of platelet-activating factor in murine candidiasis.Infect Immun1997https://conductscience.org/library/papers/9119469PubMed
8719795Role for intracellular platelet-activating factor in the circulatory failure in a model of gram-positive shock.Br J Pharmacol1995https://conductscience.org/library/papers/8719795PubMed
8423096An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.Infect Immun1993https://conductscience.org/library/papers/8423096PubMed
7743464Clinical experience with platelet-activating factor antagonists. Past, present, and near future.Clin Rev Allergy1994https://conductscience.org/library/papers/7743464PubMed
7693276Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock.Br J Pharmacol1993https://conductscience.org/library/papers/7693276PubMed
7681601A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.Proc Natl Acad Sci U S A1993https://conductscience.org/library/papers/7681601PubMed
1717219PAF. A review of its effects, antagonists and possible future clinical implications (Part II).Drugs1991https://conductscience.org/library/papers/1717219PubMed
1612734In vivo effects of the antiglucocorticoid RU 486 on glucocorticoid and cytokine responses to Escherichia coli endotoxin.Infect Immun1992https://conductscience.org/library/papers/1612734PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/2519903

GET https://conductscience.org/api/papers/v1/2519903/authors